Clin2
NCT06966856Possibly a fitNot yet recruiting

Vitamin B12 pill vs under-the-tongue for low B12 from acid medicine

Hypovitaminosis b 12

Treatments studied

This trial tests two ways to take vitamin B12 — as a pill you swallow or as a liquid under your tongue — to see which works better for people whose stomach acid medicine (PPIs) may have made their B12 levels drop. If you qualify, you'll take one of these for 6 weeks, and the study will track your B12 levels to see if they improve.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 3
Enrollment
23 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are between 18 and 70 years old.
  • You have been taking a proton pump inhibitor (such as omeprazole or esomeprazole) for 1 to 6 months.
  • Your vitamin B12 level is slightly low (between 150 and 300 pg/mL), but you have not taken B12 supplements yet.
  • You do not have long-term digestive diseases like Crohn's or celiac disease.
  • You have not had stomach or weight-loss surgery, and you do not have severe kidney, liver, or anemia problems.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT05785585Recruiting
B12 supplements test for people on a vegetarian diet

This study compares two forms of vitamin B12 to see how well they improve or maintain B12 levels in adults who eat vegetarian. It may help people understand which type of B12 works best for supporting normal B12 status.

Reus, Tarragona
NCT04527055Enrolling by invitation· Phase 4
Bismuth treatment for H. pylori: 10 or 14 days

This trial compares two common stomach medicine plans that use bismuth for 10 days versus 14 days to clear an H. pylori infection. It may help you find a shorter or more effective treatment schedule if you have H. pylori confirmed by an endoscopy.

Tainan
NCT07576959Recruiting· Phase 3
Bismuth with dual therapy for H. pylori infection treatment

This trial tests whether adding bismuth (a mineral compound) to standard two-drug therapy helps cure H. pylori, a common stomach bacteria that can cause ulcers and inflammation. The goal is to see if this combination works better than dual therapy alone.

Taipei
NCT06639789Recruiting
Vitamin B12 effect on cycling performance

This trial tests a new Vitamin B12 supplement to see if it improves physical and mental performance in cyclists. It might help if you are a healthy male cyclist training regularly.

La Ñora, Murcia
NCT07146594Not yet recruiting· Phase 4
14-day bismuth therapy for H. pylori infection

This trial tests a 14-day bismuth-based combination therapy to get rid of H. pylori, a stomach bacteria that can cause ulcers and stomach discomfort. It is being studied in an area where some standard antibiotics may not work well, offering a possible alternative treatment.

NCT05005897Recruiting· Phase 2/Phase 3
Micronutrient supplements for early infant growth and development

This study tests whether early infant nutrition using specific micronutrients (small amounts of key vitamins and nutrients) can support healthy growth and development. It includes babies whose moms plan to breastfeed for long enough, and it excludes infants with serious health problems.

Lillehammer

Hear when a new Hypovitaminosis b 12 trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.